hrp0098fc2.6 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

Expansion of the CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Outcomes After up to 2 Years of Vosoritide Treatment

Mohnike Klaus , Eibenstein Ursula , Pimenta Jeanne , Reichert Anja , Mukherjee Swati , Gausche Ruth , Beger Christoph , Pfäffle Roland

Background: CrescNet is a European pseudonymous paediatric registry of longitudinal measurements used to screen for growth disorders including achondroplasia (ACH). ACH is a rare genetic condition caused by a gain-of-function variant in the fibroblast growth factor receptor 3 (FGFR3) gene, resulting in severe disproportionate short stature and medical complications related to impaired endochondral bone growth. Vosoritide (C-type natriuretic peptide analogue) i...